期刊文献+

特大地震伤员多重耐药鲍曼不动杆菌医院感染与防控策略 被引量:3

Prevention and control strategy for 30 cases with muti drug resistant acinetobacter baumanii hospital infection from the earthquake disaster area
下载PDF
导出
摘要 目的总结特大地震伤员多重耐药鲍曼不动杆菌群聚医院的感染防控策略,开辟多重耐药鲍曼不动杆菌以及其他多重耐药株医院感染防控新思维及有效方法。方法在华西医院预分诊处对地震伤员的伤口分泌物进行细菌学检查和分析,据此提出群聚医院感染防控策略并实施。结果地震伤员中伤口分泌物30例为多重耐药鲍曼不动杆菌经过采取群聚医院感染防控策略等综合措施,共有22例伤口分泌物培养阴性,病情痊愈出院;8例伤口分泌物系多重耐药鲍曼不动杆菌,病情相对稳定,未再有其他新的地震伤员伤口分泌物培养出多重耐药鲍曼不动杆菌。结论对多重耐药鲍曼不动杆菌地震伤员采取群聚医院感染防控策略,能有效控制多重耐药鲍曼不动杆菌及其他全耐药株医院感染。 Objective To summarize the experience of preventing and controlling the infection with muti drug resistant (MDR) acinetobacter baumanii and create a new way to prevent and control such infections effectively. Methods From May 14th to June 24th, 2008, secretions for patients injured in the Wenehuan Earthquake were cultured to detect the pathogenic bacteria, followed by bringing forward a preventing strategy against such multitudinous infections. Results Up to June 24th, Baumanii, which were multidrug resistant, were detected in thirty cases. After the preventing and controlling measures were implemented, twenty-two cases recovered and discharged from the hospital, and their secretions were cultured without any bacteria. But there were still eight cases whose secretions were cultured with positive results for multidrug resistant Baumanii. Fortunely, their conditions were stable, and nobody was infected by Baumanii any more. Conclusion Preventing and controlling strategy played an effective role in preventing and controlling hospital infections, including A. baumanii.
出处 《西部医学》 2009年第9期1471-1473,共3页 Medical Journal of West China
关键词 汶川地震 多重耐药鲍曼不动杆菌 医院感染 防控策略 Wenehuan earthquake Multi drug resistant aeinetobacter baumanii(MDR) Hospital infection Preventing and controlling strategy
  • 相关文献

参考文献4

二级参考文献32

  • 1陈民钧.美国临床实验室标准化研究所2005年版有关药敏试验标准化更新要点[J].中华检验医学杂志,2005,28(4):449-451. 被引量:60
  • 2王辉,孙宏莉,廖康,陈冬梅,王清涛,王飞燕,陈民钧,朱元珏.北京和广州地区四家医院不动杆菌碳青霉烯酶基因型研究[J].中华检验医学杂志,2005,28(6):636-641. 被引量:121
  • 3Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. Clinical and Laboratory Standards Institute, Wayne, Pa.
  • 4Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbial,1995, 33 : 2233-2239.
  • 5Levesque C, Piche L, Larose C, et al. PCR mapping of integrons reveals several novel combination of resistance genes. Antimicrob Agents Chemother, 1995, 39 : 185-191.
  • 6Jeon BC, Jeong H, Bae K, et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing OXA-23 β-lactamase in Korea. J Clin Microb, 2005, 43:2241-2245.
  • 7Dalla-Costa LM, Coelho JM, Souza HAPHM, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microb, 2003, 41:3403-3406.
  • 8Villers D, Espase E, Coste-Burel M, et al. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med, 1998, 129: 182-189.
  • 9Manikal VM, Landman D, Saurina G, et al. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York.- citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis, 2000, 31 : 101-106.
  • 10Kuo L, Teng L, Yu C, et al. Dissemination of a clone of unusual phenotype of pandrug-resistant Acinetobacter baumannii at a university hospital in Taiwan. J Clin Microbiol, 2004, 42: 1759-1763.

共引文献312

同被引文献33

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部